Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13G for Compass Therapeutics, Inc. Common Stock, $0.0001 par value per share (CMPX).
- Disclosed ownership: 5.1%.
- Date of event: 22 Oct 2025.
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 5.1% ownership in Compass Therapeutics, Inc. Common Stock, $0.0001 par value per share (CMPX) on 22 Oct 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 2.7% | 4,673,550 | 0 | 4,673,550 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF I GP LLC | 2.7% | 4,673,550 | 0 | 4,673,550 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BIOTECHNOLOGY VALUE FUND II LP | 2% | 3,396,894 | 0 | 3,396,894 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF II GP LLC | 2% | 3,396,894 | 0 | 3,396,894 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| Biotechnology Value Trading Fund OS LP | 0.3% | 542,486 | 0 | 542,486 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF Partners OS Ltd. | 0.3% | 542,486 | 0 | 542,486 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF GP HOLDINGS LLC | 4.7% | 8,070,444 | 0 | 8,070,444 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF PARTNERS L P/IL | 5.1% | 8,750,000 | 0 | 8,750,000 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF INC/IL | 5.1% | 8,750,000 | 0 | 8,750,000 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| LAMPERT MARK N | 5.1% | 8,750,000 | 0 | 8,750,000 | /s/ Mark N. Lampert | Mark N. Lampert |